Author Interviews, JAMA, Urology / 03.10.2017
Hematuria, and Early Cancer Detection, Not Uncommon With Anticoagulation Medications
MedicalResearch.com Interview with:
Robert Nam, MD, FRCSC
Ajmera Family Chair in Urologic Oncology
Professor of Surgery
University of Toronto
Head, Genitourinary Cancer Site
Odette Cancer Centre
Sunnybrook Health Sciences Centre
MedicalResearch.com: What is the background for this study? What are the main findings?
Response: The well known potentially lethal complications of anti-thrombotic medications of cerebral and gastrointestinal bleeding complications are well known. However, more common bleeding related complications are not well described . In particular, gross hematuria is a well known complication of these medications but its frequency and severity is unknown. We sought to characterize this association among a large population-based cohort consisting of over 2.5 million patients from the Province of Ontario, Canada, using hematuria-related complications was endpoints. These were defined as undergoing invasive urologic procedures, hospital admissions or emergency visits for gross hematuria.
(more…)